Respiratory Health Goes High-Tech: Dry Powder Inhaler Market to Scale US$29.6 Billion by 2031, to exhibit a CAGR of nearly 4.6%

According to Future Market Insights, the global Dry Powder Inhaler Market is slated to exhibit a CAGR of nearly 4.6% during the forecast period (2021-2031), in terms of volume.

Over 4000,000 Mn units of dry powder inhalers are pegged to be sold across the globe by 2031-end.

Start Exploring Now – Download Your Complimentary Visuals Report! @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5150

Challenges Regarding Varying Characteristics of Dry Powder Inhalers to Pave Opportunities for Medical Device Manufacturers

Regulatory pressures and changes in drug delivery market have driven innovation of the dry powder inhaler forward.

According to the World Health Organization (WHO), nearly 300 Mn people worldwide are affected by asthma, and approximately 240 Mn from the chronic obstructive pulmonary disease (COPD).

Over half of these patients combined prefer use of dry powder inhalers for treatment of their disease.

These devices have depicted great potential in effective and reliable drug delivery, with novel designs ensuring the possibility to overcome future compliance, cost, and safety challenges.

Some of the essential performance characteristics regarding dry powder inhalers are associated with dose-delivery, performances at varying airflows, and fine particle fraction content.

These characteristics may vary with respect to powder formulations, creating the need for fine tuning of the device or powder formulation or both combined for achieving optimal performance.

Unlock Your Savings – Click Here for the Discount. @ https://www.futuremarketinsights.com/request-discount/rep-gb-5150

The requirement is particularly high in micro-dosing dry powder inhalers, which in turn is paving opportunities for medical device manufacturers in terms of innovations and advancements.

Growing adoption of unhealthy lifestyle, increasing geriatric population, and growing air pollution levels fuelling prevalence of various respiratory disorders are key factors driving expansion of the global dry powder inhaler market.

In addition, favorable government initiatives being taken across the globe for improving the healthcare infrastructure will further influence the market growth in the near future.

However, the fact that dry powder inhalers are not moisture-resistant remains a major challenge for manufacturers, as the medicine loses its properties when it comes in contact with the moisture.

Availability of effective alternatives such as nebulizers and electric pumps are expected to restrain adoption of dry powder inhalers.

Lack of awareness regarding these devices in low-income & underdeveloped countries may further hinder the market growth to a certain extent.

Ready to Be a Game-Changer? Download Your Impactful Report. @ https://www.futuremarketinsights.com/customization-available/rep-gb-5150

Key Research Findings from FMI’s Report on Dry Powder Inhaler Market

• North America will continue to be the most lucrative region for growth of the dry powder inhaler market. Dry powder inhaler sales in the region will register the fastest expansion through 2031. Asia-Pacific excluding Japan (APEJ) is expected to be the second largest market for dry powder inhaler.
• Hospital pharmacies will continue to be the leading distribution channel for dry powder inhalers, with sales pegged to surpass 150,000 Mn units by 2031-end.
• Dry powder inhalers will continue to observe the largest application in the treatment of asthma, followed by chronic obstructive pulmonary disease. In addition, sales of dry powder inhalers for application in the treatment of asthma and pulmonary arterial hypertension are slated to exhibit a parallel growth through 2031.

Leading companies in the global dry powder inhaler market are focusing on the development of new generation products.

These market players are making huge investments in R&D activities associated with novel device architectures, particle engineering, and powder formulations.

Key Market Segments Covered In Dry Powder Inhalers Industry Research

By Product :

• Single Dose Dry Powder Inhalers
• Multi Dose Dry Powder Inhalers

By Indication :

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Pulmonary Arterial Hypertension
• Diabetes
• Cystic Fibrosis

By Function :

• Manually Operated Inhaler Devices
• Digitally Operated Inhaler Devices

By End User :

• Institutional Sales
  • Hospital Pharmacies
  • Cancer Research
  • Office based Speciality Clinics
• Retail Sales
  • Retail Pharmacies
  • Drug Stores
• Mail Order Pharmacies

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.

Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.

Sepsis Diagnostics Market: The global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube